<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230612058457N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-06-14</date_registration>
      <primary_sponsor>Iran National Science Foundation: (INSF)</primary_sponsor>
      <public_title>Investigating the effect of flossing technique on ankle performance in athletes</public_title>
      <acronym></acronym>
      <scientific_title>The effects of tissue flossing on ankle range of motion, strength, balance, and jump performance in athletes with limited ankle dorsiflexion: a randomized control trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-06-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84055</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, individual simple randomization was performed, whereby each participant was independently assigned to either the intervention or control group. To generate the random sequence, the website www.randomizer.org was used. First, a list of eligible participants was prepared, and then the group allocation sequence was determined using the online tool provided by this website. Stratified randomization was not used in this study.

To maintain allocation concealment, the random sequence was prepared by a member of the research team, and participants’ group assignments were carried out using sealed, numbered envelopes, ensuring that participants remained unaware of their group allocation until the moment of assignment. This method helps minimize allocation bias and enhances the scientific rigor of the study.</study_design>
      <phase>3</phase>
      <hc_freetext>Limited ankle range of motion.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in this group will undergo a tissue flossing intervention. In this method, an elastic flossing band is used to apply compression around the ankle joint (at 50–60% of maximum tension), while performing active movements including ankle pumps, bodyweight squats, and lunges. Each exercise is performed in 3 sets with specific durations (based on the study protocol), and the process is repeated three times per week for a period of six weeks. The aim of this intervention is to improve range of motion, strength, balance, and jump performance through mechanisms such as increased blood flow and temporary changes in fascial tissue properties. Intervention 2: Control group: Participants in this group will perform passive stretching exercises to improve ankle range of motion. These exercises target the calf muscles (gastrocnemius and soleus), with each stretch held for 30 seconds and repeated for 3 sets, with 15 seconds of rest between sets. This intervention is carried out three times per week for a duration of six weeks. The aim of this approach is to increase ankle mobility without the use of tissue compression.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be shared after anonymizing individuals, ensuring their non-identifiability.

When:
The data access period will start immeduately after the results are printed.

To whom:
The data will be made available to researchers, organizations, and institutions related to the athletes.

Conditions:
In order to assist scientific research and promote the implementation of executive goals with a focus on enhancing the performance of athletes.

Where to obtain:
Mohammad Alimoradi/malimoradi@sport.uk.ac.ir

How to obtain:
Requests for access to data will be answered within a week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Alimoradi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 6, Yekta residential complex, Fathalishahi 12 St, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7614816961</zip>
        <telephone>+98 34 2250 1685</telephone>
        <email>malimoradi@sport.uk.ac.ir</email>
        <affiliation>Shahid Bahonar University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Alimoradi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit 6, Yekta residential complex, Fathalishahi 12 St, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7614816961</zip>
        <telephone>+98 34 2250 1685</telephone>
        <email>malimoradi@sport.uk.ac.ir</email>
        <affiliation>Shahid Bahonar University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Sex: Only male athletes will participate in the study.
Age: Individuals between 18 and 35 years old.
Limitation in ankle dorsiflexion: Having an ankle dorsiflexion range of motion less than 10 degrees (as measured using a goniometer).
No significant injury: No significant lower limb injury in the past six months.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Use of an ankle brace during the study period.
Absence from two consecutive sessions, or Absence from three non-consecutive sessions.
Lack of willingness to continue participation at any stage of the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M25.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stiffness of joint, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in this group will undergo a tissue flossing intervention. In this method, an elastic flossing band is used to apply compression around the ankle joint (at 50–60% of maximum tension), while performing active movements including ankle pumps, bodyweight squats, and lunges. Each exercise is performed in 3 sets with specific durations (based on the study protocol), and the process is repeated three times per week for a period of six weeks. The aim of this intervention is to improve range of motion, strength, balance, and jump performance through mechanisms such as increased blood flow and temporary changes in fascial tissue properties.</i_keyword>
      <i_keyword>Control group: Participants in this group will perform passive stretching exercises to improve ankle range of motion. These exercises target the calf muscles (gastrocnemius and soleus), with each stretch held for 30 seconds and repeated for 3 sets, with 15 seconds of rest between sets. This intervention is carried out three times per week for a duration of six weeks. The aim of this approach is to increase ankle mobility without the use of tissue compression.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>In the current study, the range of motion of the ankle joint is being investigated. Timepoint: Measurements will be taken at baseline (before intervention), as well as 6 and 12 weeks after implementing the protocol. Method of measurement: I tis measured using a goniomete.</prim_outcome>
      <prim_outcome>In the current study, the strength of ankle joint is being investigated. Timepoint: Measurements will be taken at baseline (before intervention), as well as 6 and 12 weeks after implementing the protocol. Method of measurement: It is assessed using an isokinetic dynamometer.</prim_outcome>
      <prim_outcome>In the current study, the dynamic balance is being investigated. Timepoint: Measurements will be taken at baseline (before intervention), as well as 6 and 12 weeks after implementing the protocol. Method of measurement: It is measured using the Y Balance test.</prim_outcome>
      <prim_outcome>In the current study, the vertical jump is being investigated. Timepoint: Measurements will be taken at baseline (before intervention), as well as 6 and 12 weeks after implementing the protocol. Method of measurement: It is measured using the Sargent jump test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran National Science Foundation: (INSF)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-04-14</approval_date>
        <contact_name>Research Ethics Committees of University of Guilan</contact_name>
        <contact_address>5th Kilometer of Persian Gulf Highway, Rasht, Guilan Province, Iran Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
